Technology
Health
Biotechnology
Ultragenyx Pharmaceutical
$57.989876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$57.98
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.55 (0.97%) Today
+$0.80 (1.40%) After Hours
Why Robinhood?
You can buy or sell RARE and other stocks, options, ETFs, and crypto commission-free!
About
Ultragenyx Pharmaceutical Inc. Common Stock, also called Ultragenyx Pharmaceutical, is a biopharmaceutical company, which engages in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Read More Its product includes Mepsevii and Crysvita. The company was founded by Emil D. Kakkis on April 22, 2010 and is headquartered in Novato, CA.
Employees
610
Headquarters
Novato, California
Founded
2010
Market Cap
3.28B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
556.03K
High Today
$58.59
Low Today
$56.80
Open Price
$57.03
Volume
108.20K
52 Week High
$90.98
52 Week Low
$37.44
Collections
Technology
Health
Biotechnology
Pharmaceutical
Biopharmaceutical
2014 IPO
US
North America
News
The Motley FoolMay 7
Ultragenyx Pharmaceutical Inc (RARE) Q1 2019 Earnings Call Transcript
Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) Q1 2019 Earnings Call , 5:00 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good afternoon. My name is Jerome, and I will be your conference operator today. At this time, I would like to welcome everyone to the Ultragenyx First Quarter 2019 Financial Results and Corporate Update. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-a...
Price Paid on Robinhood
2% Lower
Right Now
52 Week Low
$37.44
Average Price Paid
$59.45
52 Week High
$90.98
Earnings
-$2.09
-$1.46
-$0.84
-$0.21
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 1, After Hours